Cite

HARVARD Citation

    Campos Carrascosa, L. et al. (2020). FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record